脑康口服液治疗缺血性脑卒中后继发神经功能损害的疗效

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (600 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical efficacy of Naokang oral liquid in the treatment of secondary neuronal damage of patients with ischemic stroke.Methods A total of 100 ischemic stroke patients were recruited and randomly divided into study group and control group.Control group was treated with conventional medicine while study group was additionally given Naokang oral liquid. Twenty-eight days after treatment, the NIHSS score and MBI score were observed and recorded, while hemorheological changes were detected for each patient.Results Clinical symptoms of the two groups were significantly improved after treatment. After twenty-eight days of treatment, the NIHSS score in study group was decreased significantly, but the MBI score was higher than in control group, and the difference was statistically significant[(11.07±2.01)vs(14.95±1.85);(41.58±15.42)vs(36.24±13.56),P<0.05]. The hemorheological values in study group were reduced significantly compared with control group, and the difference was of statistical significance(P<0.05).Conclusions Naokang oral liquid can significantly improve the neurological function and daily activities of ischemic stroke patients. It can also remarkably improve patients’hemorheology and promote blood circulation of the brain.

Key words： Naokang oral liquid ischemic stroke the secondary neuronal damage clinical efficacy

Received: 11 August 2016

ZTFLH:

R743.3

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YAO Xiangwen
	WANG Jinyu
	WU Zhilin
	and NIU Shailong

Cite this article:

YAO Xiangwen,WANG Jinyu,WU Zhilin等. Clinical efficacy of Naokang oral liquid in treatment of secondary neuronal damage of patients with ischemic stroke[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2017, 28(3): 251-253.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2017/V28/I3/251

[1]	朱在卿,许贵刚,郭艳丽,等. 针刺干预对脑缺血大鼠脑组织低氧诱导因子-1α蛋白和mRNA表达的影响[J].武警医学,2015,26(6):551-554.
[2]	Li S Y, Gao Y, Ma W N, et al. The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population[J]. Inflammation, 2014,37(3):686-693.
[3]	Shadi Y, Andrew E, Joshua Z W. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator[J].JAMA Neurol,2014,71(9):1181-1185.
[4]	刘志刚,宁冬梅.复方丹参滴丸治疗缺血性脑卒中的临床疗效观察与生活质量评价[J].实用药物与临床,2014,17(3):286-288.
[5]	胡志洁,张志耘.三七总皂苷对心脑血管的药理作用研究[J].天津药学,2008,18(6):51-55.
[6]	黄芳.中药红花的现代药理研究进展[J].临床医学,2014,27(9):674-675.
[7]	刘雪东,李伟东,蔡宝昌.当归化学成分及对心脑血管系统作用研究进展[J].南京中医药大学学报,2010,26(2):155-157.
[8]	迟雪洁,孙蓉.川芎基于功效物质基础的抗脑缺血药理作用研究进展[J].中国药物警戒,2013,10(6):355-357.
[9]	陈赪,郭富强,段霄燕,等. 缺血性脑血管病全脑血管造影效果分析[J].武警医学,2014,25(1):26-29.
[10]	徐巧巧,陈生立,曾儒欣,等. 缺血性脑卒中患者血流动力学改变及其临床意义[J].温州医学院学报,2010,40(3):296-297.